Chidambaram, Gopal Subramanium in Novartis v. Ranbaxy; Ranbaxy injuncted from producing anti diabetes drug

The Delhi High Court yesterday restrained Ranbaxy Laboratories Ltd. from manufacturing and selling anti-diabetes medicine Vildagliptin in a suit filed by Swiss drug maker Novartis, reports Mint.